17 Results

People

  1. Moskowitz
    Moskowitz
  2. Yahalom
    Yahalom
  3. Zelenetz
    Zelenetz
  4. Nimer
    Nimer
  5. Bertino
    Bertino
  6. Hamlin
    Hamlin
  7. Matasar
    Matasar
  8. Migliacci
    Migliacci
  9. Portlock
    Portlock
  10. Straus
    Straus

Groups

  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (17)
  3. Center for Hematologic Malignancies (10)
  4. Lymphoma (10)
  5. Survivorship Research (9)
  6. Radiation Oncology, Department of (7)
  7. Nursing (4)
  8. Biostatistics Service (3)
  9. Epidemiology and Biostatistics (3)
  10. Bone Marrow Transplant (2)
  1. "cisplatin"
  2. "Craig Moskowitz"
Formats
  1. Journal Article (17)
Groups
  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (17)
  3. Center for Hematologic Malignancies (10)
  4. Lymphoma (10)
  5. Survivorship Research (9)
  6. Radiation Oncology, Department of (7)

More Groups

People
  1. Craig Moskowitz (17)
  2. Andrew Zelenetz (7)
  3. Joachim Yahalom (7)
  4. Paul Hamlin (4)
  5. Stephen Nimer (4)
  6. Carol Portlock (3)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2014 (2)
  5. 2013 (1)
  6. 2012 (2)

More Years

Publications
  1. Blood (3)
  2. Bone Marrow Transplantation (3)
  3. Biology of Blood and Marrow Transplantation (2)
  4. Journal of Clinical Oncology (2)
  5. Annals of Oncology (1)
  6. Best Practice and Research: Clinical Haematology (1)

More Publications

Publishers
  1. Elsevier Inc. (4)
  2. American Society of Hematology (3)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (2)
  5. Harborside Press (1)
  6. John Wiley & Sons (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of relapsed and refractory primary mediastinal (thymic) large B cell lymphoma treated with second-line therapy and intent to transplant
    Journal Article

    Vardhana, S.; Hamlin, P. A.; Yang, J.; Zelenetz, A.; Sauter, C. S.; Matasar, M. J.; Ni, A.; Yahalom, J.; Moskowitz, C. H.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma
    Journal Article

    Zinzani, P. L.; Ribrag, V.; Moskowitz, C. H.; Michot, J. M.; Kuruvilla, J.; Balakumaran, A.; Zhang, Y.; Chlosta, S.; Shipp, M. A.; Armand, P.
    Blood (2017)

    Fulltext@MSK | Save
  • Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
    Journal Article

    Van Den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Linch, D.; Trneny, M.; Milpied, N.; Radford, J.; Ketterer, N.; Shpilberg, O.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Journal Article

    Dahi, P. B.; Tamari, R.; Devlin, S. M.; Maloy, M.; Bhatt, V.; Scordo, M.; Goldberg, J.; Zelenetz, A. D.; Hamlin, P. A.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project
    Journal Article

    Carson, K. R.; Newsome, S. D.; Kim, E. J.; Wagner-Johnston, N. D.; Von Geldern, G.; Moskowitz, C. H.; Moskowitz, A. J.; Rook, A. H.; Jalan, P.; Loren, A. W.; more...
    Cancer (2014)

    Fulltext@MSK | Save
  • Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
    Journal Article

    Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20+ diffuse large B-cell lymphoma: Final analysis of the collaborative trial in relapsed aggressive lymphoma
    Journal Article

    Gisselbrecht, C.; Schmitz, N.; Mounier, N.; Gill, D. S.; Linch, D. C.; Trneny, M.; Bosly, A.; Milpied, N. J.; Radford, J.; Ketterer, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Diffuse large B cell lymphoma: How can we cure more patients in 2012?
    Journal Article

    Moskowitz, C.
    Best Practice and Research: Clinical Haematology (2012)

    Fulltext@MSK | Save
  • Hodgkin lymphoma: Clinical practice guidelines in oncology
    Journal Article

    Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Bello, C. M.; Bierman, P. J.; Blum, K. A.; Dabaja, B.; Duron, Y.; Forero, A.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: Results from two transplant centres
    Journal Article

    Smith, S. D.; Moskowitz, C. H.; Dean, R.; Pohlman, B.; Sobecks, R.; Copelan, E.; Andresen, S.; Bolwell, B.; Maragulia, J. C.; Vanak, J. M.; more...
    British Journal of Haematology (2011)

    Fulltext@MSK | Save